A meta-analysis demonstrated that mPDAC patients whose tumors displayed a high number of tumor-infiltrating lymphocytes (TILs) had improved OS, especially when the TILs were located in the tumor center [37], suggesting that strategies aimed at increasing the infiltration of CD8+ T cells might improve the response to ICIs. This evidence concerns the gene CD8A and neoplasm.